New Zealand - English - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - diclofenac potassium 25mg;  ;  ;  ;   - tablet - 25 mg - active: diclofenac potassium 25mg         excipient: calcium phosphate colloidal silicon dioxide dispersed red (ferric oxide 3% + titanium dioxide 97%) macrogol 8000 magnesium stearate maize starch microcrystalline cellulose opacode brown s-1-9210hv povidone   purified talc sodium starch glycolate sucrose - short-term treatment in the following acute conditions: - post-traumatic pain, inflammation and swelling, e.g. due to sprains; - post-operative pain, inflammation and swelling, e.g. following dental or orthopaedic surgery; - painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; - migraine attacks; - painful syndromes of the vertebral column; - non-articular rheumatism; - as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - diclofenac potassium, quantity: 25 mg - capsule, soft - excipient ingredients: medium chain triglycerides; lecithin; purified water; macrogol 400; povidone; gelatin; brilliant blue fcf; propylene glycol; titanium dioxide; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; sorbitol; glycerol - for the temporary relief of painful conditions such as headache, dental pain, period pain, rheumatic and muscular pain, backache. for the temporary,relief of pain and discomfort associated with cold and flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline consumer healthcare australia pty ltd - diclofenac potassium -

Canada - English - Health Canada

teva canada limited - diclofenac potassium - tablet - 50mg - diclofenac potassium 50mg - other nonsteroidal antiimflammatory agents

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - diclofenac potassium - film coated tablet - 50 milligram - acetic acid derivatives and related substances

United States - English - NLM (National Library of Medicine)

amici pharmaceuticals llc. - diclofenac potassium (unii: l4d5ua6cb4) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac potassium tablets and other treatment options before deciding to use diclofenac potassium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings: gastrointestinal bleeding, ulceration, and perforation). diclofenac potassium tablets are indicated: diclofenac potassium tablets are contraindicated in the following patients:

United States - English - NLM (National Library of Medicine)

a-s medication solutions - diclofenac potassium (unii: l4d5ua6cb4) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac potassium tablets and other treatment options before deciding to use diclofenac potassium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings: gastrointestinal bleeding, ulceration, and perforation). diclofenac potassium tablets are indicated: - for treatment of primary dysmenorrhea - for relief of mild to moderate pain - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis diclofenac potassium tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (see warnings: anaphylactic reactions, serious skin reactions). - history of asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fat

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - diclofenac potassium (unii: l4d5ua6cb4) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac potassium tablets and other treatment options before deciding to use diclofenac potassium tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings: gastrointestinal bleeding, ulceration, and perforation). diclofenac potassium tablets are indicated: - for treatment of primary dysmenorrhea - for relief of mild to moderate pain - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis diclofenac potassium tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product (see warnings: anaphylactic reactions, serious skin reactions). - history of asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients (see warnings: anaphylactic reactions, exacerbation of asthma related to aspirin sensitivity). - in the setting of coronary artery bypass graft (cabg) surgery (see warnings: cardiovascular thrombotic events).

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis consumer health uk limited - diclofenac potassium - film coated tablet - 12.5 milligram - acetic acid derivatives and related substances

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - diclofenac sodium - gastro-resistant tablet - 25mg